Fifth Third Bancorp
CGTX icon

Fifth Third Bancorp’s Cognition Therapeutics CGTX Stock Holding History

Fifth Third Bancorp’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.8K Hold
5,000
– – ﹤0.01% 3928
2025
Q4 		$6.75K Buy
+5,000
New +$8.12K ﹤0.01% 2247

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Fifth Third Bancorp's CGTX Position: Q1 2026 in Review

Fifth Third Bancorp held its Cognition Therapeutics (CGTX) position steady in Q1 2026 at 5,000 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3928.

Fifth Third Bancorp first reported a position in CGTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.75K in Q4 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Fifth Third Bancorp held 5,000 shares of Cognition Therapeutics worth $3.8K as of Q1 2026.
  • Fifth Third Bancorp left its Cognition Therapeutics share count unchanged in Q1 2026.
  • Cognition Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3928 holding.
  • Fifth Third Bancorp first reported a position in Cognition Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Fifth Third Bancorp's Cognition Therapeutics position peaked at $6.75K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.